Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study

Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys

(2013) Yoshiki Yamagami et al.   BONE

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

(2013) Nelson Watts et al.   Endocrine Practice

A review of minodronic acid hydrate for the treatment of osteoporosis

(2013) Shinji Tanishima et al.   Clinical Interventions in Aging

A comparative study of the effects of daily minodronate and weekly alendronate on upper gastrointestinal symptoms, bone resorption, and back pain in postmenopausal osteoporosis patients

(2012) Toru Yoshioka et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summary

(2012) Hajime Orimo et al.   Archives of Osteoporosis

Three years of treatment with minodronate in patients with postmenopausal osteoporosis

(2011) Hiroshi Hagino et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis

(2011) R. Okazaki et al.   OSTEOPOROSIS INTERNATIONAL

Management of osteoporosis in postmenopausal women

(2010) &NA;   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Validation of the Japanese Osteoporosis Quality of Life Questionnaire

(2009) Keigo Kumamoto et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Subtype-Specific Regulation of P2X3 and P2X2/3 Receptors by Phosphoinositides in Peripheral Nociceptors

(2009) Gary Mo et al.   Molecular Pain

Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models

(2008) Shuichiro Kakimoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users

(2008) Jeffrey R Curtis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of daily oral minodronate on vertebral fractures in Japanese postmenopausal women with established osteoporosis: a randomized placebo-controlled double-blind study

(2008) T. Matsumoto et al.   OSTEOPOROSIS INTERNATIONAL

Compliance and persistence with osteoporosis therapies

(2008) Stuart L. Silverman et al.   Current Rheumatology Reports